Zobrazeno 1 - 10
of 53
pro vyhledávání: '"S. Carenzi"'
Autor:
T. Zaccaria, I. Franchi, F. Zamboni, A. Marzano, A. Barbui, A. Franchello, S. Carenzi, V. Ghisetti, G. Marchiaro
Publikováno v:
Microbiologia Medica, Vol 18, Iss 2 (2003)
Externí odkaz:
https://doaj.org/article/aa99a7b9a6cd4cdcae87da31166dfd08
Autor:
Carlo Alessandria, S. Carenzi, Antonina Smedile, Valeria Barbon, Antonella Olivero, Mario Rizzetto, Silvia Gaia, Alfredo Marzano, M. Lagget
Publikováno v:
Journal of Hepatology. 48:540-547
In lamivudine-resistant patients with chronic hepatitis B (CHB), we compared efficacy, predictive response factors and changes in viral mutants in two antiviral approaches with adefovir.A prospective cohort study on therapy with adefovir alone (29 pa
Autor:
Alessandro Franchello, Mario Rizzetto, R. Romito, Vincenzo Mazzaferro, Massimo Colombo, Alfredo Marzano, Andrea Pulvirenti, Mauro Viganò, S. Carenzi, Pietro Lampertico, Mauro Salizzoni
Publikováno v:
Liver Transplantation. 11:532-538
The combination of lamivudine and hepatitis B immunoglobulin (HBIG) reduces the risk of hepatitis B virus (HBV) recurrence after liver transplantation (LT). However, the efficacy of this strategy and the need for combined therapy with adefovir dipivo
Autor:
Giovannino Ciccone, Aldo Manca, Alessia Ciancio, G. Tappero, S. Carenzi, Alberto Biglino, Pier Giulio Orsi, G. Croce, Marco Tabone, Antonina Smedile, Massimo Andreoni, A. Olivero, Mario Rizzetto, Giuseppe Cariti, Giorgio Maria Saracco, Luigi Roffi
Publikováno v:
Hepatology. 36:959-966
To determine whether a higher dosage of interferon (IFN) and/or a prolonged time of administration may improve the efficacy of combination therapy, we conducted a 4-arm randomized trial on patients with chronic hepatitis C relapsing after 1 or more p
Autor:
Maurizio Cassader, Amalia Gastaldelli, Gian Paolo Caviglia, Roberto Gambino, C. Saponaro, Maria Lorena Abate, Ester Vanni, Melania Gaggini, Chiara Rosso, Mario Rizzetto, Fabrizia Carli, Lavinia Mezzabotta, Elisabetta Bugianesi, S. Carenzi, Emma Buzzigoli, Federico Salamone, Francesca Saba, Antonina Smedile
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f2349a2c406071a5c13819fe23ad69
http://hdl.handle.net/2318/142639
http://hdl.handle.net/2318/142639
Autor:
Demetrio Ciociaro, Chiara Rosso, Ester Vanni, Gian Paolo Caviglia, Melania Gaggini, Mario Rizzetto, Roberto Gambino, Maria Lorena Abate, Francesca Saba, Antonina Smedile, S. Carenzi, Lavinia Mezzabotta, Amalia Gastaldelli, Federico Salomone, Elisabetta Bugianesi, Emma Buzzigoli, Maurizio Cassader, C. Saponaro
Publikováno v:
Journal of Hepatology. 60:S352-S353
P840 ALTERATION IN LIPID METABOLISM AFTER AN ORAL FAT LOAD IN PATIENTS WITH NAFLD L. Mezzabotta, E. Vanni, C. Rosso, M. Gaggini, R. Gambino, E. Buzzigoli, C. Saponaro, D. Ciociaro, M.L. Abate, F. Saba, F. Salomone, G.P. Caviglia, S. Carenzi, A. Smedi
Autor:
S. Carenzi, Amalia Gastaldelli, Maurizio Cassader, Elisabetta Bugianesi, Lavinia Mezzabotta, C. Saponaro, Ester Vanni, Melania Gaggini, Francesca Saba, Antonina Smedile, Emma Buzzigoli, Demetrio Ciociaro, Mario Rizzetto, Chiara Rosso, Maria Lorena Abate, Gian Paolo Caviglia, Roberto Gambino, Federico Salomone
Publikováno v:
Digestive and Liver Disease. 46:e53-e54
Autor:
Silvia Gaia, Alfredo Marzano, Antonina Smedile, Franco Brunello, Elisabetta Bugianesi, Angela L. Barilli, Mario Rizzetto, S. Carenzi
Publikováno v:
Journal of hepatology. 54(1)
Transient elastography (TE) is validated in chronic hepatitis C (CHC) to evaluate hepatic fibrosis; however, limited data are available in chronic hepatitis B (CHB) and non-alcoholic fatty liver disease (NAFLD). This prospective study is aimed to ass
Autor:
Fabrizia Carli, Emma Buzzigoli, Maurizio Cassader, Amalia Gastaldelli, C. Saponaro, Gian Paolo Caviglia, Demetrio Ciociaro, S. Carenzi, Roberto Gambino, M.L. Abate, Melania Gaggini, Francesca Saba, Ester Vanni, Lavinia Mezzabotta, A. Smedile, Chiara Rosso, Elisabetta Bugianesi, Mario Rizzetto
Publikováno v:
Journal of Hepatology. 62:S509
Autor:
S. Carenzi, Mario Rizzetto, Mauro Salizzoni, Alessandro Franchello, Alfredo Marzano, Carlo Alessandria, A. Premoli, W. Debernardi-Venon, Valeria Ghisetti, Silvia Gaia
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 11(4)
Hepatitis B virus (HBV) recurrence after liver transplantation is significantly reduced by prophylaxis with hepatitis B immune globulins (HBIG) or antiviral drugs in nonreplicating patients and by the combination of both drugs in replicating patients